Press Releases
Asia's First Bioprocessing Research and Training Institute to Open in South Korea
The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry.
Under the agreement, the two ministries will build Asia's first state-run bioprocessing research and training institute in Korea. In response to a surge in biomedicine manufacturing in Korea, 60 billion won ($51.3 million) is set to be invested by 2025 to provide advanced training for professionals and resolve imbalances in staffing. This investment is expected to effectively establish Korea as a major biocluster in Asia.
The South Korean government agencies, the Ministry of Trade, Industry and Energy, and the Ministry of Health and Welfare announced plans to foster Asia's bioprocessing professionals. Dr. Tae Han Kim, CEO of Samsung Biologics attended the signing ceremony to support the agreement with aims to further strengthen and expand Korea's bio-industry.
Under the agreement, the two ministries will build Asia's first state-run bioprocessing research and training institute in Korea. In response to a surge in biomedicine manufacturing in Korea, 60 billion won ($51.3 million) is set to be invested by 2025 to provide advanced training for professionals and resolve imbalances in staffing. This investment is expected to effectively establish Korea as a major biocluster in Asia.